Affordable Access

Treatment of primary dysmenorrhea with mefenamic acid.

Authors
Type
Published Article
Journal
International Journal of Gynecology & Obstetrics
0020-7292
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
18
Issue
3
Pages
172–175
Identifiers
PMID: 6109648
Source
Medline

Abstract

Thirty-five patients (16--23 years old) who had severe primary dysmenorrhea were each treated with 500 mg of mefenamic acid every eight hours for a maximum of three days during menstruation for three consecutive cycles. A total of 194 treated cycles could be evaluated, 110 cycles with mefenamic acid and 84 with placebo. Mefenamic acid produced complete relief of all the symptoms of dysmenorrhea in 31 (88.6%) patients in all 98 treated cycles and, in another two patients, moderate relief in five of the six cycles. While on placebo, only five patients (13%) experienced moderate to slight relief in 11 of the 15 cycles. It is concluded that the mefenamic acid is safe and effective in most patients for the relief of primary dysmenorrhea and represents a rational short-term therapy for this syndrome.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments